The preS1 antigen of hepatitis B virus is highly immunogenic at the T cell level in man.
14 hepatitis B vaccine recipients who showed high titers of anti-hepatitis B surface antibodies in serum after booster immunization with a polyvalent hepatitis B surface antigen vaccine that contained trace amounts of hepatitis B virus (HBV) preS1 and preS2 envelope antigens were studied for their i...
Salvato in:
| Pubblicato in: | J Clin Invest |
|---|---|
| Autori principali: | , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
American Society for Clinical Investigation
1989
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC329792/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2529268/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI114299 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
